JP2004517853A - 歯周病の治療方法及び治療用組成物 - Google Patents

歯周病の治療方法及び治療用組成物 Download PDF

Info

Publication number
JP2004517853A
JP2004517853A JP2002554050A JP2002554050A JP2004517853A JP 2004517853 A JP2004517853 A JP 2004517853A JP 2002554050 A JP2002554050 A JP 2002554050A JP 2002554050 A JP2002554050 A JP 2002554050A JP 2004517853 A JP2004517853 A JP 2004517853A
Authority
JP
Japan
Prior art keywords
phenyl
methyl
cox
methylsulfonyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002554050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004517853A5 (https=
Inventor
ハートマン，ジヨージ・デイー
ロダン，セブギ・ビー
ロダン，ギデイオン・エー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JP2004517853A publication Critical patent/JP2004517853A/ja
Publication of JP2004517853A5 publication Critical patent/JP2004517853A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP2002554050A 2001-01-03 2001-12-28 歯周病の治療方法及び治療用組成物 Withdrawn JP2004517853A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25944101P 2001-01-03 2001-01-03
PCT/US2001/049638 WO2002053099A2 (en) 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease

Publications (2)

Publication Number Publication Date
JP2004517853A true JP2004517853A (ja) 2004-06-17
JP2004517853A5 JP2004517853A5 (https=) 2005-12-22

Family

ID=22984959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002554050A Withdrawn JP2004517853A (ja) 2001-01-03 2001-12-28 歯周病の治療方法及び治療用組成物

Country Status (5)

Country Link
EP (1) EP1349548A4 (https=)
JP (1) JP2004517853A (https=)
AU (1) AU2002246757B2 (https=)
CA (1) CA2432504A1 (https=)
WO (1) WO2002053099A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
PL3050878T3 (pl) 2013-09-24 2022-01-24 Fujifilm Corporation Zawierający atom azotu związek lub jego sól, lub ich kompleks z metalem
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
TR200001752T2 (tr) * 1997-12-17 2000-12-21 Merck & Co., Inc. Entegrin reseptör antagonistleri
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
AU747784B2 (en) * 1998-07-29 2002-05-23 Merck & Co., Inc. Integrin receptor antagonists
PT1187592E (pt) * 1999-06-02 2007-10-19 Merck & Co Inc Antagonistas dos receptores de integrina alfa v

Also Published As

Publication number Publication date
WO2002053099A2 (en) 2002-07-11
AU2002246757B2 (en) 2006-02-02
EP1349548A2 (en) 2003-10-08
WO2002053099A3 (en) 2002-09-12
CA2432504A1 (en) 2002-07-11
EP1349548A4 (en) 2004-06-02

Similar Documents

Publication Publication Date Title
Davidovitch et al. Cyclic AMP levels in alveolar bone of orthodontically-treated cats
US6232315B1 (en) Method for treating inflammatory diseases by administering a thrombin inhibitor
Sarı et al. Comparison of some effects of acetylsalicylic acid and rofecoxib during orthodontic tooth movement
EA025421B1 (ru) Лечение липодистрофии
JP2008502609A (ja) リウマチおよび関節性疾患の治療改善方法
CZ20014289A3 (cs) Nové pouľití sloučenin jako antibakteriálních činidel
HRP980356A2 (en) Prostaglandin agonists
MXPA01011302A (es) Terapias de combinacion para la estimulacion de crecimiento oseo.
HU203670B (en) Process for producing pharmaceutical composition containing basically modificated insuline derivatives and zinc-ions for treating diabetes mellitus
JP3832229B2 (ja) フェニルエテンスルホンアミド誘導体含有医薬
US20020040039A1 (en) Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
JP2004517853A (ja) 歯周病の治療方法及び治療用組成物
US20040053968A1 (en) Methods and compositions for treating peridontal disease
AU2002246757A1 (en) Methods and compositions for treating periodontal disease
JP2004532230A (ja) Ｐｐａｒ−ガンマアクチベーターを使用する瘢痕化および関連状態の処置
TWI306760B (en) Use of an endothelin et-a receptor antagonist and orally delivered pharmaceutical composition comprising the same
JP2006096665A (ja) 脊柱管狭窄症治療剤
JPWO2003024484A1 (ja) 掻痒症治療剤
WO2006079243A1 (fr) Emploi du flavonol et des glycosides de type flavonol dans la stimulation de la croissance des cellules épithéliales rénales tubulaires pour sécréter le facteur de croissance osseuse
JP7178143B1 (ja) 爪幹細胞及び毛髪の成長を助長する外用剤
JP6994243B2 (ja) 歯牙移動促進剤及び矯正歯科治療用キット
JP4677705B2 (ja) 頭痛の予防および／または治療剤
JP2005503346A (ja) 片頭痛を治療するための方法及び組成物
JP2018090540A (ja) 歯槽骨吸収抑制剤
CN102387804A (zh) 骨代谢异常所引起的疾病的预防药或治疗药

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20041214

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20041214

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20070119